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Dicentric chromosomes have been identiﬁed as instigators of the genome instability associated with cancer, but this instability is
often resolved by one of a number of diﬀerent secondary events. These include centromere inactivation, inversion, and intercen-
tromeric deletion. Deletion or excision of one of the centromeres may be a signiﬁcant occurrence in myeloid malignancy and
other malignancies but has not previously been widely recognized, and our reports are the ﬁrst describing centromere deletion in
cancer cells. Wereview whatis knownabout dicentric chromosomesand the mechanisms by which they can undergo stabilization
in both constitutional and cancer genomes. The failure to identify centromere deletion in cancer cells until recently can be partly
explained by the standard approaches to routine diagnostic cancer genome analysis, which do not identify centromeres in the
context of chromosome organization. This hitherto hidden group of primary dicentric, secondary monocentric chromosomes,
together with other unrecognized dicentric chromosomes, points to a greater role for dicentric chromosomes in cancer initiation
and progression than is generally acknowledged. We present a model that predicts and explains a signiﬁcant role for dicentric
chromosomes in the formationof unbalanced translocations in malignancy.
1.Introduction
Dicentric chromosomes, which have two centromeres, are a
well-known feature of cancer cells, and the genome instabil-
ity and evolution they induce are highly relevant to cancer
biology [1, 2]. Although constitutional dicentric chromo-
somes are much rarer, in those that havebeen identiﬁed there
is little evidence of this instability. Our studies have shown
that the mechanisms by which dicentric chromosomes are
stabilized include the loss of a centromere from a dicentric
chromosome making it secondarily monocentric [3, 4], a
previously little known mechanism which may be relatively
commonin cancerevolution.Wereview evidencethatdicen-
tric chromosomes have a greater role in oncogenesis than is
currently acknowledged.
During cell division the two centromeres of an unstable
dicentric chromosome migrate towards opposite polesat an-
aphase, causing cyclesof breakageand rejoining which create
new chromosome arrangements, deletions, and ampliﬁca-
tions. This is known as the bridge-fusion-breakage (BFB)
cycle [5] .T h eg e n ec o p yn u m b e ra b e r r a t i o n sw h i c ha r ea
byproduct of dicentric chromosome instability can create an
increased risk of malignancy. Positive selection of these copy
number changes can drive clonal evolution [6–10].
Copy number aberration (CNA) in the genome—net
gain or loss of genetic material—is seen as one of the major
causes of cancer. CNA can occur by whole chromosome
gain or loss (aneuploidy), simple deletion or duplication of
a chromosome segment, or unbalanced translocation where
rearrangement betweentwoormorechromosomesproduces
net gain or loss of material. Isodicentric chromosome for-
mation causes both gain and loss of material, by the joining
together of sister chromatids at a double-strand break, and is
one method by which unstable dicentric chromosomes can
be produced [11, 12].
Dicentricchromosomesinconstitutional(nonmalignant)
genomes are typically either stable at formation, or have2 Genetics Research International
undergone a process of stabilization by mechanisms which
havebeenwell studied[13–16].Theprocesses underlying the
stabilization of dicentric chromosomes in cancer cells have
not been so well deﬁned.
We will compare patterns of dicentric chromosome sta-
bilization in the cancer and constitutional settings, including
insights gained from our studies of cases of acute myeloid
leukemia (AML) and myelodysplastic syndromes (MDS)
with unbalanced karyotypes.
2.DicentricChromosomesinMalignancy
Dicentric chromosomes in cancer are best known as the
product of telomere fusion events. Telomeres cap and stabi-
lize the ends of chromosomes. Loss of this protective func-
tion, such as by a gradual reduction in the number of DNA
telomere-speciﬁc repeats as a consequence of repeated ge-
nome replication, creates sticky chromosome ends. These
can join to each other, with or without complete loss of the
residual telomere and subtelomere sequences [17, 18]. Ap-
parent telomere fusion (telomere association) events are
characteristic of certain tumours, such as giant cell tumor
of the bone [19] and meningioma [20]. Several model sys-
temshavebeendevelopedforcreatingand studying dicentric
chromosomes in vitro or in nonhuman organisms, by arti-
ﬁcially induced telomere erosion [7, 10, 18, 21–23]. Recent
studies have reported direct molecular evidence for naturally
occurring telomere fusion in cancer cells [6, 24].
Studies of dicentric chromosomes in vivo, in vitro,a n d
in mice with induced telomere dysfunction, support a major
role for telomere erosion and subsequent end-to-end chro-
mosome fusion in causing the genome instability which is
observed in many types of cancer [6, 8, 21, 22, 24–26], al-
though this has also recently been questioned [27]. The BFB
cycle undergone by these dicentric chromosomes is under-
stood to be one of the principle causes of genome instability
[11, 26, 28].
Unstable dicentric chromosomes can produce rearrange-
ments such as deletion, ampliﬁcation, inversion, double
minute, and ring chromosomes [9, 28, 29]. Micronuclei and
other nuclear anomalies can be produced as byproducts of
instability. These contain centric or acentric chromosome
segments which have not segregated to either daughter cell
[26, 30]. Lagging of dicentric chromosomes so that they are
then lost to a micronucleus, or missegregation of the whole
dicentric chromosome to one daughter cell, can produce
whole chromosome aneuploidy [21, 26].
Studies of transformed cell lines and premalignant cells
have shown that with continued cell division and shortening
of the telomeres, the cells enter a period of crisis, which is as-
sociatedwith end-to-end fusion ofthechromosomes and ge-
nome instability, causing genome aberration. These cells
with aberrant genomes would normally undergo senescence,
but can survive if p53-induced apoptosis is inactivated. Tel-
omerelengthandstabilityarerestoredbyupregulationoftel-
omerase or the alternative lengthening of telomere (ALT)
mechanism [6, 8, 31–34].
Translocation between two or more chromosomes with
interstitial breakpoints (reciprocal translocation) can also
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Figure 1: Translocations described in the text. (a) Telomere Fusion,
creating a dicentric chromosome with minimal DNA loss but
potentially causing secondary copy number aberration via the BFB
cycle. (b) Dicentric Translocation, a reciprocal translocation pro-
ducing a dicentric chromosome, and an acentric chromosome
which is lost at cell division; (c) Balanced Reciprocal Transloca-
tion, producing two monocentric chromosomes—another event is
required for CNA to occur. Our model proposes that (a) and (b),
which both produce a dicentric chromosome, are the major causes
of unbalanced translocation.
produce dicentric chromosomes (Figure 1). Hematological
malignancies have the most well characterized chromosome
abnormalities of any malignancy, and most dicentric chro-
mosomes reported in hematological malignancies have a
morphology consistent with this type of rearrangement
rather than telomere fusion. Morphology can be misleading
however, and there is now evidence that over half of the
dicentric chromosomes involving chromosome 20 in mye-
loidmalignancy are formedbytelomerefusion events[35].It
is not yet known whether this pattern extends to other chro-
mosomes.
Dicentric chromosomes which have been identiﬁed in
hematological malignancies include the recurrent dic(17;20)
[36, 37] and dic(5;17) [38] in MDS and AML and the
dic(9;20) in acute lymphoblastic leukemia [39], as well as a
range of other abnormalities [3, 39–41]. These are usually
interpreted as unbalanced reciprocal translocations (see
Figure 1), with breakpoints often described at or near the
centromere [40, 42, 43]. The dic(9;20) is an unusual case.
While most dicentric chromosomes, including the recurrent
dic(17;20) [4], appear to have a range of breakpoints on
both chromosomes, the dic(9;20) has been shown to have
breakpoints within a single gene on 9p, PAX5,c r e a t i n ga
fusion gene between this gene and a number of diﬀerent
genes on 20q [44–47].
Studies which focus on the identiﬁcation of dicentric
chromosomes in hematological malignancies have tended to
uncover a higher incidenceof dicentric chromosomes than is
usually reported. In one ofthe rare studies into the incidence
of dicentric chromosomes in myeloid malignancy, Andersen
and Pedersen-Bjergaard [42] identiﬁed a dicentric chromo-
some in15%(27/180)ofconsecutivecasesoftherapy-related
AML (t-AML) and t-MDS and a much lower incidence inGenetics Research International 3
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Figure 2: (a-b) G-banded chromosomes. (a) A typical stable dic(17;20) (centre) with the normal 20 (left) and 17 (right) from the
same metaphase (Case 3 of Patsouris et al. [36]). (b–d) examples from a case with a highly variable dic(17;20) (Case 6 of MacKinnon
et al. [4], SVH01 of MacKinnon et al. [48]). (b) Left, normal chromosome 20 and unstable dic(17;20) from a single metaphase. Right,
two secondarily monocentric chromosomes with a 17 centromere (der(17)) from the same patient—each was derived from the primary
dic(17;20) translocation by rearrangements which included loss of the 20 centromere. Both show a monocentric morphology and neither
is easily recognizable as a pseudodicentric chromosome. (c) FISH images of the normal chromosome 20 and the two der(17)s illustrated
in (b) (from a single metaphase). False colour images after FISH show the 20 centromere (red) (missing from the der(17)s), 17 centromere
(aqua) (present in the der(17)s), and chromosome 20 content (green). (d-e) Two dic(17;20)s from the case illustrated in (b) and (c), both
of which have secondary rearrangements bringing the centromeres closer together. (d) Blue, chromosomes stained with DAPI; green, whole
chromosome 20 paint; red 20 centromere; (e) Blue, 17 centromere; green, whole chromosome 20 paint; red, 20 centromere. The derivatives
shown have (i) inversion of chromosome 20 material and (ii) deletion of intercentromeric material.
de novo disease (0.4%). The combined incidence for AML
and MDS was 8%. Callet-Bauchu et al. [41]i d e n t i ﬁ e da
highincidenceofdicentricchromosomes(10/14)among17p
translocations in chronic B-lymphoid disorders.
3.DicentricChromosomesin
Myeloid Malignancy
Adiverserangeofcytogeneticaberrationshasbeendescribed
in the myeloid malignancies AML and MDS, including high-
ly speciﬁc balanced translocations producing fusion genes,
and copy number aberrations. Our studies of in vivo kary-
otype abnormalities in patients with these diseases have re-
vealed a high incidence of dicentric chromosomes in unbal-
anced translocations involving chromosome 20.
We characterized the centromere and chromosome con-
tent and organization of 32 unbalanced chromosome 20
translocations, including thirteen unbalanced 17;20 translo-
cations [3, 4, 36, 48]. These 32 cases had been identiﬁed as
having apparent monosomy 20 (24 cases) and/or a 17;20
translocation (13 cases) (ﬁve cases fulﬁlled both criteria).
Most had lost the putative tumor suppressor gene (TSG) re-
gion at 20q12.
Eight cases of dic(17;20) had a typical morphology
comprised of 20p, 17q, and the proximal regions of 20q
and 17p between the two centromeric constrictions [3, 36]
(Figure 2(a)). A further ﬁve cases had a variant 17;20 trans-
location derived by secondary rearrangement of a primary
dicentric chromosome [4, 48] (e.g., Figures 2(b)–2(e)).
Thus, every one ofthirteen 17;20 translocation productsthat
we identiﬁed had been formed as a dicentric chromosome
[4, 36, 48],
Twenty-one of 24 cases (87.5%) with apparent mono-
somy 20 (including the ﬁve variant 17;20 translocations)
were shown to have a primary dicentric translocation, and
only six of these appeared to have no secondary rearrange-
mentorepigeneticinactivationofacentromere(Table 1)[3].
There was not enoughinformation todetermine whether the
translocations of the remaining three cases had been derived
from dicentric chromosomes.
These ﬁndings point to a hidden body of dicentric chro-
mosomes in myeloid malignancy, that can only be identiﬁed
bydetailedcharacterization. Inareviewofdicentricchromo-
somes in hematological malignancies, Berger and Busson-Le
Coniat [40]reportedthattheidentiﬁcationofdicentricchro-
mosomesisincreasedwhenﬂuorescenceinsituhybridization
(FISH) with speciﬁc α- s a t e l l i t eD N Ap r o b e si su s e da n d
suggested that the true incidence is higher than realized. Our
studies show that even the use of centromere probes will not
identify all dicentric translocations, because some primary
dicentric chromosomes become secondarily monocentric.
Our evidence points to a frequency of primary dicentric
chromosomes in AML/MDS which is higher than the 8%
reported by Andersen and Pedersen-Bjergaard [42]a n di s4 Genetics Research International
Table 1:Patterns ofsecondary chromosomeaberrationderived from 32primary dicentric (20;var) chromosomesincases ofAML andMDS
described in previous publications. In total eleven cases had some mechanism of secondary centromere deletion and had retained or lost
the deleted segment, and eight had another type of rearrangement which produced an altered (secondary) dicentric chromosome which
retained both chromosomes (four cases had mixtures of clones exhibiting both mechanisms).
Secondary event MacKinnon and
Campbell [3]
MacKinnon et al.
[4]
Patsouris et al.
[36]
MacKinnon et al.
[48] Total
N o c h a n g e 641 1 1
Centromere inactivation 3 3
Intercentromeric deletion 1 1
Inversion reducing intercentromeric distance 3 3
Cases with secondary monocentric chromosomes:
Mixture of clones: intercentromeric
deletion/centromere deleted 11
Mixture of clones: intercentromeric
deletion/centromere excised and retained in a ring
chromosome
11
Centromere deleted 5 5
Centromere excised and retained in a ring
chromosome 22
Complex mixture of clones: dicentric and
secondary rearrangements (centromere deletion,
excision of centric ring, inversion, deletion)
11 2
T o t a l 2 1 611 2 9
potentially as high as the frequency of unbalanced transloca-
tionsinAML/MDS.Inourlaboratory during2009and 2010,
the frequency of karyotypes with unbalanced translocation
in new cases of MDS or AML was 18%.
4.Stabilizationof DicentricChromosomesin
Myeloid Malignancy
These detailed studies of dicentric chromosomes in cases of
AML and MDS gave us the opportunity to identify some of
the mechanisms by which dicentric chromosomes had been
stabilized. In 18/29 primary dicentric chromosomes, some
or all of the cells had undergone secondary events which
could be interpreted as producing a more stable derivative.
A summary of these diﬀerent secondary events is presented
in Table 1. One case had a highly unstable dic(17;20) with
26Mb between the centromeres, that had produced a wide
range of derivatives (Figure 2)[ 4]. The variety of rearrange-
ments is reminiscent of those described by Riboni et al. [2]
in a dicentric chromosome which was produced by telomere
fusion in vitro.
Centromere suppression occurred by functional inacti-
vation (which was assumed when α-satellite DNA was still
present but there was no centromeric constriction) or by
excision of the α-satellite DNA.(Centromere suppression re-
fers to loss of centromere function, regardless of how this is
achieved). Loss of centromere-speciﬁc α-satellite DNA from
the chromosome was the most common type of secondary
rearrangement. The dicentric chromosome of 11 cases had
become secondarily monocentric, by deletion of a centro-
mere from a primary dicentric chromosome. In some cases
the excised segment containing the centromere was retained
in the cell as what appeared to be a ring chromosome
(Table 1).
We identiﬁed loss of the 20, 6, or 17 centromere in
these cases [3, 4]. We have also identiﬁed cases where there
has been loss of the 17 centromere from a primary dicen-
tric chromosome not involving chromosome 20 (RNM, un-
published results; Figure 3). Similar studies will be needed
to determine if centromere deletion occurs more widely in
dicentrics involving other chromosomes and in other malig-
nancies.
Somesecondary rearrangements were producedbyinter-
centromeric deletion or inversion of the inferred primary
dicentric chromosome (Figures 2(d),2(e)). These rearrange-
ments produced dicentric derivatives with a greatly reduced
intercentromeric distance, apparently resulting in stable
dicentric chromosomes. The stable dicentric chromosomes
showing no evidence of secondary events had short inter-
centromeric distances, supporting studies in constitutional
dicentric chromosomes which show that this property ren-
ders the dicentric chromosome stable [14, 49].
More than half of the dic(20;var) which had lost the
20q12 TSG region had done so by an interstitial deletion,
retaining the distal, subtelomeric 20q region [35]. Based on
evidence that dicentric chromosomes can occur by telomere
fusion, the simplest explanation of our ﬁndings was that an
unstable primary dicentric chromosome had been formed
by telomere fusion between chromosome 20 and another
chromosome, followed by positive selection of a derivative
with a secondary 20q12deletion(see Figure 1). However, the
alternative explanation, translocation between a preexisting
del(20q)andanotherchromosome, couldnotbediscounted.Genetics Research International 5
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Figure 3: FISH images of three partial metaphases from a case with a dic(16;17) and derivatives formed by loss of the 17 centromere. The
normal 17 is also present in each image. (a–c) Blue, chromosomes; red, TP53 (a 17p13 locus); green, whole chromosome 17 paint; (d–f).
Each image shows the same view as the image above it but the labelled 17 centromere is visible: blue, 17 centromere; red TP53.( a )( i )a
dic(16;17)(q12.1;p13).(b-c) derivatives of the dic(16;17). (b) (ii) a der(16) (the 17 centromere has been lost). (c) (iii) a der(16) and (iv) the
deleted segment containing the 17 centromere and TP53. Methods for FISH were as described in MacKinnon et al. [4].
Wehavedescribedﬁvecasesofdic(17;20)with interstitial
deletionof 20q suggestive of telomere fusion and subsequent
deletion of the 20q12 TSG containing region [4, 35, 48].
A telomere fusion between 17p and 20q would produce a
dicentric chromosome with an intercentromeric distance of
56Mb. According to studies of constitutional dicentric chro-
mosomes [14, 49] a dicentric chromosome with this inter-
centromericdistancewouldbeunstable.Thus, thesecondary
deletion of 20q12 could fulﬁll two roles: loss of a TSG and
stabilization of the dicentric chromosome.
We havealso reported localized ampliﬁcation ofa section
of 20q (20q11.21), in both MDS and AML, the development
of which was probably aided by its position between the
centromeres of unstable dicentric chromosomes [3, 48]. We
have suggested that this selectively ampliﬁed region contains
an oncogene [3, 48]. As well as deletion, the BFB cycle can
cause ampliﬁcation of material between the centromeres of a
dicentricchromosome.Positiveselectivepressurewouldtend
to favor ampliﬁcation of an oncogene in this position. Gain
of the whole abnormal chromosome in other cases, rather
than localized ampliﬁcation, provides further support for on
oncogenic role for a gene in this region. Further instances
of ampliﬁcation of 20q11.21 have been identiﬁed since these
publications (RNM, unpublished observations).
5. CentromereDeletion
Centromere deletion or excision has only rarely been de-
scribed previously. Nevertheless, it was a signiﬁcant event
in our series (occurring in 11 of 29 primary dicentrics) and
was more frequent than functional inactivation. FISH with
BAC (bacterial artiﬁcial chromosome) clones was used to
deﬁne the breakpoints of20 centromere deletion[48], which
fell into two main categories. Some had deletion break-
points close to the centromere, retaining part or all of the
ﬂanking BACs (two published cases [48] and one unpub-
lished case (RNM, unpublished results)), while others had
excision of a broader section including 20q11.21, and the
excised fragment was retained in the cell as either a ring or
marker chromosome (4 cases). We have also observed larg-
er deletions spanning the centromere without retention of
the deleted segment (chromosome 17, one case and chromo-
some 20, two cases) [4, 48]. Some cases had multiple clones
with diﬀerent centromere deletion events. There was no
FISH evidence of partial retention of the centromere in any
of these cases.
Inthe1970sitwassuggestedthatcentromeresuppression
couldbea result ofeitherdeletionofthe centromereorfunc-
tionalinactivation[50–52].However,molecularstudiessince6 Genetics Research International
then have identiﬁed epigenetic mechanisms for suppressing
centromeres, that is, loss of the centromere proteins which
form the kinetochore, produces a functionally inactive cen-
tromere [13, 53]. These studies were carried out on consti-
tutional dicentric chromosomes, but it seems to have
been generally assumed that functional inactivation is also
the mechanism of centromere suppression in cancer cells
(e.g., [40]). Although dicentric chromosomes are commonly
found in cancer cells, mechanisms stabilizing these dicentric
chromosomes have not been well studied.
In humans, centromere deletion from a dicentric chro-
mosome has been noted most often in constitutional dicen-
tric Y chromosomes [54–57] ,b u ta l s oi nah a n d f u lo fo t h e r
cases [58, 59]. The α-satellite DNA was found to be only
partially removed in some of these, including the two exam-
ples of isodicentric Y chromosome which were studied in
detailbyTyler-Smithetal.[54],alandmark studywhichused
these deletions to identify α-satellite DNA as the sequence
marking the centromere. In some cases [55, 56, 58, 59]t h e
excised section, including the centromere, was preserved in
a small stably transmitted marker chromosome. Rivera et al.
[55, 56] identiﬁed at least six cases with pseudodicentric Y
chromosomes in which the excised Y centromere was still
present, in a small marker chromosome. These authors have
suggested that centromere excision from pseudodicentric Y
chromosomes with retention of the excised section is under-
diagnosed, because these marker chromosomes can usually
only be detected by FISH [55].
Centromere deletion has also been identiﬁed in yeast.
Artiﬁcially created dicentric chromosomes in Saccharomyces
cerevisiae can be stabilized by deleting a section of DNA con-
taining one centromere [60, 61].
Stimpson et al. [7] observed partial α-satellite deletion
in dicentric human chromosomes that were created in vitro,
in ﬁbrosarcoma cell lines. However, these dicentric chromo-
somes had been artiﬁcially induced by in vitro abrogation of
telomere function.
Our studies identifying centromere deletion in MDS and
AML combined FISH for speciﬁc centromeres with tradi-
tional cytogenetics, multicolor FISH (M-FISH), and multi-
color banding (M-BAND) [3, 4, 48]. To our knowledge ours
are the ﬁrst studies identifying centromere deletion from
naturally occurring cancer chromosomes. Centromere dele-
tion or excision was the most common mechanism of dicen-
tric chromosome stabilization that we identiﬁed in abnor-
malities of chromosome 20. This suggests that there is a sig-
niﬁcant rate of unidentiﬁed centromere deletion in cancer
genomes.
6.FunctionalInactivationofaCentromere
While dicentric chromosomes are relatively common in can-
cer cells, they are rare in the constitutional setting, probably
because most events causing genome imbalance are incom-
patible with embryo viability. Nevertheless, most stud-
ies of in vivo dicentric chromosome stabilization in hu-
mans have been carried out on constitutional dicentric chro-
mosomes discovered through clinical cytogenetic analysis.
Stabilization of these dicentric chromosomes has generally
occurred by the time of discovery [13–16].
The most commonly reported constitutional dicentric
chromosomes are Robertsonian translocations and isodicen-
tric X chromosomes—which have lost nonessential material.
Stability is typically achieved through close physical proxim-
ity of the centromeres [14, 49] or suppression of one of the
centromeres [16, 62, 63].
In a series of isodicentric X chromosomes in patients
withTurnersyndrome,SullivanandWillard [49]determined
that an intercentromeric distance of 12Mb or less is com-
patible with a stable, functionally dicentric chromosome
(in which both centromeres are active), whereas a larger
intercentromeric distance is not compatible with stability.
Dicentrics with more material between the centromeres
(at least 34Mb in their examples and 15Mb in a recent
paper by Ewers et al. [64]) consistently had only one active
centromere. Available evidence points to a requirement for
rapid stabilization of a dicentric chromosome with well-
separated centromeres, if the (nonmalignant) cells are to
remain viable [49, 65, 66].
Centromeresuppressioninconstitutionaldicentricchro-
mosomes with well-separated centromeres has most often
been shown to be achieved by functional inactivation,
producing a pseudodicentric chromosome. Functional inac-
tivation occurs by loss of the centromere proteins which
assemble at the kinetochore and deﬁne an active centromere
[13, 53, 67–70]. Antibodies to some of these epigenetic
markers, CENP-A, CENP-C, and CENP-E, have commonly
been used to distinguish between functionally active and
inactive centromeres [7, 13, 53]. Page and Shaﬀer [14]
showed that the centromere-speciﬁc alpha satellite DNA of
both centromeres was maintained in dicentrics with one
inactive centromere.
Even in stable dicentric chromosomes with closely
apposed centromeres, there is usually a mixture of cells
with one or two active centromeres, as has been shown in
Robertsoniantranslocations [13,14],isodicentricXchromo-
somes [49, 71], and other constitutional dicentrics [50, 66].
The patterns of inactivation seen in parent-child pairs were
consistent with stable transmission of the centromere in
either the active or inactive state, with a gradual progression
towards loss of functionality of either centromere if both
were inherited in the active state [14]. In cultured cells there
tended to be a higher proportion offunctional monocentrics
(structural dicentrics with one active centromere) [13, 14],
consistent with a tendency to centromere inactivation but
not reactivation.
It is not known whether centromere reactivation occurs
in vivo in humans. The presence of CENP-A is usually a
prerequisite to kinetochore assembly in humans [68, 72–
74]. However, centromere DNA lacking centromere proteins
can be reconstituted (reactivated) in yeast, maize, and
mammalian artiﬁcial chromosomes in vitro [75–78]. Also,
in rare instances a new human centromere (neocentromere)
can be created at a position na¨ ıve of centromere α-satellite
DNA by assembly of the necessary proteins, to preserve a
marker chromosome that lacks a native centromere [79].
Thissuggeststhatreactivationofahumancentromerein vivoGenetics Research International 7
is possible, but there have been no conclusive reports of this
occurring [14, 15, 59, 80, 81].
Stimpson et al. [7] looked at mechanisms of stabilization
of artiﬁcially created dicentric chromosomes. The fate of the
centromeres in these dicentric chromosomes was followed
from the time the dicentric chromosomes were formed.
There was progressive centromere suppression after several
generations by functional inactivation and, less commonly,
partial deletion of α-satellite DNA at the centromeres as
noted above.
Stabilization of double-strand DNA breaks in dicentric
chromosomes by the addition of new telomeres has been de-
scribed in mouse embryonic stem cells and tumor cells [17,
82, 83]. Similarly, splitting of a dicentric chromosome into
two monocentric derivatives has been described in humans
[2]a n dy e a s t[ 84].
7.IdentiﬁcationofDicentricChromosomesand
SecondaryRearrangements
A number of factors can explain why secondary centromere
deletion in malignancy had not been recognized earlier.
These include the tendency to explain pseudodicentric chro-
mosomes as having been derived by centromere inactivation
and the infrequency of testing for the presence of centro-
meres in routine metaphase cytogenetic analysis. In our ex-
perience, monocentric chromosomes derived from dicentric
chromosomeswere oftenonlyidentiﬁedafteradetailedanal-
ysis of centromere content, chromosome content, and orga-
nization.
FISHstudiestodetectpairsofcentromeresare notusual-
ly carried outon metaphase chromosomes during diagnostic
cancer cytogenetic analysis. The chromosomes that are most
likely to be recognized as dicentric are those stable primary
dicentric chromosomes that have two distinct centromeric
constrictions or a recognizable pseudodicentric morphology
spanning both centromeres. Other secondary monocentric
chromosomes are morphologically unrecognizable because
of the altered morphology around the centromere, as is
the case with chromosome 20 morphology after the centro-
mere has been deleted [3, 85]( Figure 2(b)). Furthermore,
dicentric chromosomes that break into two monocentric de-
rivatives might not be identiﬁed as having been derived from
a primary dicentric chromosome.
The useofarraykaryotyping(singlenucleotidepolymor-
phism—SNP—and comparative genomic hybridization—
CGH—arrays) on its own for cytogenetic analysis will not
identify dicentric chromosomes, telomere fusion, or centro-
mere deletion. Centromeres and telomeres are not repre-
sented on standard microarrays, nor do microarrays give
information on translocation partners orchromosome orga-
nization.Asresidualtelomeresequencecanberetainedatthe
site of telomere fusion [2, 6, 86], there will not necessarily be
lossof thedistal part ofthe chromosome that is detectableby
microarrays, in dicentric chromosomes formed by telomere
fusion. In the two cases of apparent telomere fusion that
we analyzed by array CGH [48], there was no detectable
terminal deletion of 20qter, nor did the arrays show any
indication of the centromere loss that had occurred. This
may have clinical implications. Dicentric chromosomes may
have a poorer prognosis because they can be subject to more
rapid selective evolution.
If on any derivative chromosome both translocation
partners contain material spanning the centromeres, this is
the strongest indication that there was a primary dicentric
translocation. A method for identifying chromosome con-
tent(arraykaryotyping,M-BAND,ortraditionalbanding)in
conjunction with FISH for the centromeres (using a pancen-
tromere probe or speciﬁc centromere probes or, more eﬃ-
ciently, multicolor centromere FISH (cenM-FISH) which
will identify all the centromeres in one step [87])andameth-
od for identifying translocation partners (M-FISH or tradi-
tionalbanding)canthereforehelpidentifydicentricchromo-
somes, including primary dicentric chromosomes which
have lost one of the centromeres. M-BAND [88]g i v e si n f o r -
mation on gross chromosome content and organization
within an individual cell and also helps deﬁne diﬀerent
clones.Itcan helpshed lightontherearrangementsthathave
occurred, if this information is not provided by standard
karyotyping. It may not be practical to carry out this level of
analysis in routine diagnostics, but for a full understanding
of the causes and consequences of unbalanced translocation
in a research context, it may be essential.
8.Th eT i po fth eI c e be rg?
Ourstudieshighlight a higherincidenceofprimary dicentric
chromosome formation in unbalanced chromosome 20
abnormalities than has previously been recognized. The
dic(20;var) appearsto be an example of an unstable dicentric
chromosome creating selectable derivatives that can allow
rapid clonal evolution.
Ourstudiessuggestedagreaterrolefortelomerefusionin
creating dicentric chromosomes in myeloid malignancy than
has been previously acknowledged. Environmental and bio-
logical factors associated with telomere erosion, that is, ad-
vancing age and chemical exposure, are also risk factors for
developing MDS and AML [43, 89–91], and so identifying
a high incidence of telomere fusion as an oncogenic event
may help identify the causes of these diseases. Complex kar-
yotypes often include many unbalanced translocations, fre-
quentlyofunknowncomposition,and theresulting chromo-
somes are typically assumed to be monocentric unless there
is clear evidence to the contrary. Given the apparently high
incidence of unidentiﬁed chromosome 20 dicentrics in mye-
loid malignancy, we suggest that other unbalanced trans-
locations in AML, MDS, and other malignancies may also
harbor a higher incidence of dicentric chromosomes than is
currently recognized. This would suggest that the instability
associated with dicentric chromosomes is a much more sig-
niﬁcant factor incancerthanis apparent.Weproposeamod-
el that both explains the high incidence of dicentric chromo-
somes in unbalanced chromosome 20 translocations and
makes the more general prediction that dicentric chromo-
some formation is a major mechanism for unbalanced chro-
mosome translocation in malignancy.8 Genetics Research International
9.Model forthe FormationofUnbalanced
Translocationsby DicentricTranslocation
This model suggests that most unbalanced translocations are
formed by one of two mechanisms producing a dicentric
chromosome,dicentrictranslocation,a n dtelomerefusion.Ge-
nome imbalance is a direct consequence of both of these
events. Three types of translocation are deﬁned.
(i) Telomere Fusion (end-to-end joining of chromo-
somes at the telomeres): this is a balanced rearrange-
ment (apart from possible telomere and subtelomere
loss), but if the centromeres are well separated,
the chromosome is unstable and further rearrange-
ments are likely—including oncogenic deletions and
ampliﬁcations—creating an unbalanced transloca-
tion product.
(ii) Dicentric Translocation: a simple reciprocal translo-
cation producing a dicentric and an acentric chro-
mosome. As the acentric chromosome is lost during
mitosis, this becomes an unbalanced translocation.
(iii) Balanced Reciprocal Translocation: a simple reciprocal
translocation producing two monocentric chromo-
somes. There is no net gain or loss of material and
another event would be required to produce copy
number aberration. Therefore we suggest that this
is not a usual cause of genome imbalance, contrary
to the tacit assumption that the products of most
oncogenic unbalanced translocations are monocen-
tric.
The novel aspect of this model is that it predicts that
dicentric chromosomes play a much greaterrole in oncogen-
esis than is currently appreciated and gives a smaller role to
balanced reciprocal translocation in the generation of copy
number imbalance. A signiﬁcant role for dicentric chromo-
somes produced by telomere attrition in causing genome
instability is already recognized. Our chromosome 20studies
provide evidence for both mechanisms of dicentric chromo-
some formation and support only a minor or coincidental
role for reciprocal translocation producing two monocentric
chromosomes.
10.Conclusions
Dicentric chromosomes are rarely identiﬁed in constitu-
tional genetics. However, in cancer cells the formation of
dicentric chromosomes is a well-recognized event, which
may contribute to the malignant phenotype and clonal evo-
lution. We have explored the patterns of stabilization of di-
centric chromosomes in constitutional karyotypes, cancer
cells, and cells in tissue culture.
Our studies have shed a light on the role of dicentric
chromosome formation in myeloid malignancy. Many pri-
mary dicentric chromosomes escape detection when tradi-
tional or molecular karyotyping is used to characterize ge-
nome aberrations. We have uncovered a signiﬁcant role for
centromere deletion or excision in the evolution of mye-
loid malignancy, which raises the possibility that this occurs
more widely, and in other cancers. More detailed studies
combining molecular karyotyping (which allows precise
breakpoint deﬁnition and genome-wide detection of copy
numberaberration)withFISHstudies(whichallowchromo-
some organization and centromere content to be deter-
mined) will lead to a better understanding of the role of di-
centric translocations in cancer.
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